NITRD requests information on AI research, development plan

The Networking and Information Technology Research and Development (NITRD) Program is seeking information on the National Artificial Intelligence (AI) Research and Development Strategic Plan.

The program filed a request for information on the AI research plan in an effort to decide if it should be revised and improved. The request was published on Wednesday, Sept. 26.

According to the request, the AI research and development plan was developed in 2016 as a way to guide government efforts in AI research and development and listed seven strategic aims. The NITRD program is a multiagency source of federally funded work on advanced information technologies (IT).

"Through this (RFI), NITRD seeks input from the public, including those directly performing (AI) research and development and directly affected by such R&D, on whether the strategic plan should be revised and, if so, the ways in which it may be improved," the request states.

"This includes suggestions as to the addition, removal, or modification of strategic aims, comments as to existing strategic aims as well as their past or future implementation by the Federal government."

Responses to the request can be submitted through Oct. 26.

""

Danielle covers Clinical Innovation & Technology as a senior news writer for TriMed Media. Previously, she worked as a news reporter in northeast Missouri and earned a journalism degree from the University of Illinois at Urbana-Champaign. She's also a huge fan of the Chicago Cubs, Bears and Bulls. 

Around the web

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.